2.Clinical profile of pediatric patients with COVID‐19 admitted to Southern Philippines Medical Center before vaccine rollout
Rica Marie B. Andico ; Ameleen B. Bangayan ; Jo-anne J. Lobo
Southern Philippines Medical Center Journal of Health Care Services 2025;11(1):1-3
Human
;
Philippines
;
Patients
;
Vaccines
;
Covid‐19
3.Clinical profile, management and outcome of patients diagnosed with Bronchiectasis enrolled in the Chronic Lung Disease Program in a tertiary pediatric hospital from 2021-2023
Danielle P. Barretto ; Jenni Rose D. Dimacal
The Philippine Children’s Medical Center Journal 2025;21(1):1-17
OBJECTIVE:
This study described bronchiectasis profiles at the Philippine Children’s Medical Center (2021-2023).
MATERIALS AND METHODS:
A retrospective chart review at PCMC analyzed the demographic profile, imaging, management and outcome of patients with bronchiectasis enrolled in the Chronic Lung Disease Program from 2021-2023.
Results:
Twenty seven patients were included in this study. Most patients were diagnosed after the age of six and showed female predominance. The most common symptom at the time of diagnosis was chronic cough (81.5%) with pulmonary tuberculosis (51.9%) as the most common etiology. All patients were treated with cyclic azithromycin. Pseudomonas aeruginosa was the prevalent microorganism isolated in the sputum and tracheal aspirate samples of the patients (56.5%).
Conclusion
Patients with bronchiectasis were more commonly diagnosed in children past age of six with more prevalence in females. The most common symptom was chronic cough followed by fever, dyspnea and weight loss. Pulmonary tuberculosis and recurrent respiratory infections were noted to be the most common etiology with the left lower lobe most affected in HRCT. The most common phenotype seen was cystic, which is irreversible and a sign of progressive bronchiectasis, which may point to a late diagnosis. This emphasizes the need for physicians to have a high index of suspicion in patients with chronic or recurrent respiratory symptoms. All patients were treated with an oral macrolide with 25-31% of patients with decreased and/or absent symptoms. Pseudomonas aeruginosa was the prevalent microorganism isolated in the sputum and tracheal aspirate samples of the patients, which should be taken into account when treating for exacerbation.
Human
;
Male,Female
;
Infant newborn: First 28 days after birth
;
Infant: 1-23 months
;
Child Preschool: 2-5 yrs old
;
Child: 6-12 yrs old
;
Bronchiectasis
;
Patients
;
Tuberculosis
;
Infections
4.Guideline for the diagnosis and treatment of common neonatal diseases in primary healthcare institutions: neonatal transport (2025).
Chinese Journal of Contemporary Pediatrics 2025;27(7):759-769
Neonatal transport is a crucial aspect of clinical work in neonatology, aimed at timely and safely transferring high-risk neonates from birth facilities or primary healthcare institutions to neonatal centers equipped for critical care. This ensures timely diagnosis and treatment, thereby reducing mortality and complications and improving outcomes. Currently, there is significant regional variation in neonatal transport practices across China. In response, the Subspecialty Group of Neonatology of Society of Pediatrics of Chinese Medical Association and the Editorial Board of Chinese Journal of Contemporary Pediatrics have jointly developed the "Guideline for the diagnosis and treatment of common neonatal diseases in primary healthcare institutions: neonatal transport (2025)". This guideline addresses 10 clinical issues related to neonatal transport and formulates 18 recommendations based on the best available evidence and expert consensus. It aims to provide a systematic approach to neonatal transport in primary care settings, tailored to the national context of China, offering guidance and decision-making support for primary healthcare providers.
Humans
;
Infant, Newborn
;
Primary Health Care
;
Infant, Newborn, Diseases/diagnosis*
;
Transportation of Patients/standards*
5.Design of portable respiratory device for transporting premature infants and application in the in-hospital transportation of extremely premature infants in primary hospitals.
Lijuan ZHANG ; Shuiqin GU ; Ping ZHENG ; Xiaoyi JI ; Huafei HUANG
Chinese Critical Care Medicine 2025;37(7):684-687
OBJECTIVE:
To design a portable respiratory device for transporting premature infants and explore its application effect in the in-hospital transportation of extremely premature infants in primary hospitals.
METHODS:
A prospective randomized controlled trial was conducted. The extremely premature infants born and transferred to neonatal intensive care unit (NICU) with oxygen therapy support from May to October in 2023 were selected and randomly divided into control group and observation group. The infants in the control group received respiratory support and in-hospital transportation using a traditional T-combination resuscitator connected to pure oxygen, and those in the observation group used a portable premature infant transport respiratory device designed and manufactured by medical staff to provide respiratory support and implement in-hospital transportation. The respiratory device for transporting premature infants is made of 304 stainless steel material, mainly consisting of a T-combination resuscitator, an air oxygen mixer, an air tank, a pure oxygen cylinder, a pressure reducing valve, a telescopic rod, a tray, a hook, a bottom plate, and four moving wheels, which can achieve precise control of the fraction of inspired oxygen (FiO2) during transportation. The achievement rate of first-time target pulse oxygen saturation (SpO2, achieving a target SpO2 of 0.90-0.95 was considered as meeting the standard) and arterial partial pressure of oxygen (PaO2) after being transferred to the NICU, as well as the manpower expenditure and time required for transportation of pediatric patients between the two groups were observed.
RESULTS:
A total of 73 extremely premature infants were enrolled, including 38 in the control group and 35 in the observation group. There was no significant difference in the gender, gestational age at birth, birth weight, mode of delivery, Apgar score at 1 minute and 5 minutes after birth, and oxygen therapy during the transportation between the two groups. The achievement rate of first-time target SpO2 after NICU in the observation group was significantly higher than that in the control group [94.29% (33/35) vs. 26.32% (10/38), P < 0.05], the PaO2 control range was better [mmHg (1 mmHg = 0.133 kPa): 85.50±6.36 vs. 103.00±2.83, P < 0.05], manpower expenditure and time required for transportation were significantly reduced [manpower expenditure (number): 2.14±0.35 vs. 3.17±0.34, time required for transportation (minutes): 10.42±0.76 vs. 15.54±0.34, both P < 0.05].
CONCLUSIONS
The portable respiratory device for transporting premature infants is used for respiratory support during the transportation of extremely premature infants in primary hospitals. It can improve the achievement rate of target SpO2, control PaO2 within the target range, and avoid hypoxia or hyperoxia during transportation. The breathing apparatus is compact, easy to carry, can save labor resources and time during transport, is cost-effective, and is suitable for widespread application in primary hospitals.
Humans
;
Infant, Newborn
;
Transportation of Patients
;
Prospective Studies
;
Equipment Design
;
Infant, Extremely Premature
;
Intensive Care Units, Neonatal
;
Infant, Premature
6.Characteristics of gut microbiota determine effects of specific probiotics strains in patients with functional constipation.
Haohao ZHANG ; Lijuan SUN ; Zhixin ZHAO ; Yao ZHOU ; Yuyao LIU ; Nannan ZHANG ; Junya YAN ; Shibo WANG ; Renlong LI ; Jing ZHANG ; Xueying WANG ; Wenjiao LI ; Yan PAN ; Meixia WANG ; Bing LUO ; Mengbin LI ; Zhihong SUN ; Yongxiang ZHAO ; Yongzhan NIE
Chinese Medical Journal 2024;137(1):120-122
8.The effects of spirituality on the quality of life among cancer patients enrolled in the out patient chemotherapy clinic of a Tertiary Hospital: An analytical cross-sectional study
Michael Ge-Ray H. Punzalan ; Paulo B. Tioleco ; Noel S. Chua
Philippine Journal of Internal Medicine 2024;62(1):255-261
Introduction:
Spirituality was defined as a way individual seek and express meaning and purpose and the way they
experience their connectedness to the moment. Studies showed that spiritual beliefs provided comfort to cancer patients
and that different dimensions were related with the different aspects of health.
Objectives:
The aim of the study is to determine the correlation on effects of spirituality and the quality of life among
patients enrolled in the outpatient chemotherapy clinic.
Methodology:
An analytical cross-sectional study using a non-probability convenience sampling was done of which
validated questionnaires on the Spirituality and Quality of Life were the research instruments of the study. The Pearson’s
correlation coefficient/Spearman rho computed on the relationship between the dimensions of spirituality and subscales
of the quality of life among cancer patients. Chi Square/Fisher’s test was used to determine the correlation among the types
and stages of cancer with the quality of life and spirituality of the respondents.
Results:
A total of 105 cancer patients participated in this study, with ages ranging from 21 to 76 years and a mean age of
51 +/- 11 years, 2/5 were married females and 4/5 were Roman Catholic. Fifty-six percent of the cancer patients have
Invasive Ductal Carcinoma (Breast Cancer). Most of the respondents are at stages 2 and 3 with equal percentages of 41%.
This study revealed that most of the cancer patients enrolled in the outpatient chemotherapy clinic had a mean score of
3.56 + 0.35 indicating moderate to high level of spirituality. It also showed a mean score of 5.41 +.53 indicating high QOLs.
Dimensions of spirituality which were found to have significant association with QOL domains (p < 0.05) were Mindfulness
and Feeling of Security which were both found to have positive correlation with Emotional Wellbeing and Social Status.
Conclusion
Spiritual care should be included as one of the non-pharmacological modalities in the comprehensive
management and palliative care for the Filipino cancer patients in order to improve the over-all well-being, healthcare
outcomes and quality of life of patients and their families.
Neoplasms
;
Patients
;
Quality of Life
10.A comparative analysis of the clinical symptoms of benign paroxysmal positional vertigo between older and young and middle-aged patients.
Rui Le FANG ; Qi LENG ; Yan WANG ; Mei Mei CHEN ; Yu CUI ; Xiao bing WU ; Yi JU
Chinese Journal of Internal Medicine 2023;62(7):802-807
Objective: To compare the differences in clinical symptoms and the time required for diagnosis of benign paroxysmal positional vertigo (BPPV) between older patients and young and middle-aged patients in the structured inquiry of dizziness history. Methods: The medical records of 6 807 patients diagnosed with BPPV from the Vertigo Database of Vertigo Clinical Diagnosis, Treatment, and Research Center of Beijing Tiantan Hospital, Capital Medical University, between January 2019 and October 2021 were retrospectively analyzed. The data included basic demographic information, clinical symptoms in a structured medical history questionnaire, and the time interval from the appearance of BPPV symptoms to diagnosis consultation. The patients were divided into the young and middle-aged group (<65 years old) and the older group (≥65 years old). The differences in clinical symptoms and consultation time were compared between these two groups. Categorical variables were represented by numbers (%), and compared using Chi-squared tests or Fisher's exact probability test for analysis; whereas, continuous variables conforming to normal distribution were represented by mean±standard deviation. Both data groups were compared and analyzed by Student's t-test. Results: The mean age of the older group was 65-92 (71±5) years, while the mean age of the middle-aged group was 18-64 (49±12) years. The incidence of vertigo (42.5% vs. 49.1%, χ2=23.69, P<0.001); vertigo triggered by changes in position of the head or body (52.4% vs. 58.7%, χ2=22.31, P<0.001); and autonomic symptoms (10.1% vs. 12.4%, χ2=7.09, P=0.008) were lower, but hearing loss (11.8% vs. 7.8%, χ2=27.36, P<0.001) and sleep disorders (18.5% vs. 15.2%, χ2=11.13, P=0.001) were higher in the older group than in the young and middle-aged group. The time from the appearance of dizziness to diagnosis was commonly longer in the older patient group than the other group (55.0% vs. 38.5%, χ2=55.95, P<0.001). Conclusions: Older patients with BPPV have more atypical symptoms and complex concomitant symptoms than young and middle-aged patients. For older patients with dizziness, positional testing is needed to confirm the possibility of BPPV even if the clinical symptoms are atypical.
Middle Aged
;
Humans
;
Aged
;
Aged, 80 and over
;
Adolescent
;
Young Adult
;
Adult
;
Benign Paroxysmal Positional Vertigo/therapy*
;
Dizziness/diagnosis*
;
Retrospective Studies
;
Patients
;
Surveys and Questionnaires


Result Analysis
Print
Save
E-mail